Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2023 Earnings Call Transcript November 6, 2023
Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.32 EPS, expectations were $-1.24.
Operator: Good morning and welcome to Axsome Therapeutics Third Quarter 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode. Later, there will be a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a...
